120 related articles for article (PubMed ID: 20038311)
1. [Comparative proteomic approach in differentiating multicentric occurrence and intrahepatic metastasis in multinodular hepatocellular carcinomas].
Su M; Li LQ; Peng T; Guo Y; Xiao KY; Shang LM; Xu BH; Li SL; Su ZX; Ye XP
Chin J Cancer; 2010 Jan; 29(1):52-8. PubMed ID: 20038311
[TBL] [Abstract][Full Text] [Related]
2. [Protein profiles of multinodular hepatocellular carcinoma with multicentric occurrence or with intrahepatic metastasis].
LI M; GUO K; KANG XN; SUN L; SHU H; LI RL; XU MH; LIU YK; QIN X; LI S
Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):354-8. PubMed ID: 19497201
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic characteristics and prognoses for multicentric occurrence and intrahepatic metastasis in synchronous multinodular hepatocellular carcinoma patients.
Li SL; Su M; Peng T; Xiao KY; Shang LM; Xu BH; Su ZX; Ye XP; Peng N; Qin QL; Chen DF; Chen J; Li LQ
Asian Pac J Cancer Prev; 2013; 14(1):217-23. PubMed ID: 23534727
[TBL] [Abstract][Full Text] [Related]
4. Novel proteomic biomarker panel for prediction of aggressive metastatic hepatocellular carcinoma relapse in surgically resectable patients.
Tan GS; Lim KH; Tan HT; Khoo ML; Tan SH; Toh HC; Ching Ming Chung M
J Proteome Res; 2014 Nov; 13(11):4833-46. PubMed ID: 24946162
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C.
Blanc JF; Lalanne C; Plomion C; Schmitter JM; Bathany K; Gion JM; Bioulac-Sage P; Balabaud C; Bonneu M; Rosenbaum J
Proteomics; 2005 Sep; 5(14):3778-89. PubMed ID: 16097030
[TBL] [Abstract][Full Text] [Related]
6. Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas.
Long J; Lang ZW; Wang HG; Wang TL; Wang BE; Liu SQ
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):296-305. PubMed ID: 20525558
[TBL] [Abstract][Full Text] [Related]
7. Comparative proteomic analysis of mouse livers from embryo to adult reveals an association with progression of hepatocellular carcinoma.
Lee NP; Leung KW; Cheung N; Lam BY; Xu MZ; Sham PC; Lau GK; Poon RT; Fan ST; Luk JM
Proteomics; 2008 May; 8(10):2136-49. PubMed ID: 18425728
[TBL] [Abstract][Full Text] [Related]
8. Identification of two portal vein tumor thrombosis associated proteins in hepatocellular carcinoma: protein disulfide-isomerase A6 and apolipoprotein A-I.
Xu X; Wei X; Ling Q; Cheng J; Zhou B; Xie H; Zhou L; Zheng S
J Gastroenterol Hepatol; 2011 Dec; 26(12):1787-94. PubMed ID: 21649721
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic features between multicentric occurence and intrahepatic metastasis of multiple hepatocellular carcinomas related to HBV.
Wang J; Li Q; Sun Y; Zheng H; Cui Y; Li H; Zhou H; Hao X
Surg Oncol; 2009 Mar; 18(1):25-30. PubMed ID: 18640032
[TBL] [Abstract][Full Text] [Related]
10. Differential proteomics identification of HSP90 as potential serum biomarker in hepatocellular carcinoma by two-dimensional electrophoresis and mass spectrometry.
Sun Y; Zang Z; Xu X; Zhang Z; Zhong L; Zan W; Zhao Y; Sun L
Int J Mol Sci; 2010 Mar; 11(4):1423-33. PubMed ID: 20480028
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of multicentric hepatocellular carcinomas: comparison with intrahepatic metastasis.
Shimada M; Hamatsu T; Yamashita Y; Rikimaru T; Taguchi K; Utsunomiya T; Shirabe K; Sugimachi K
World J Surg; 2001 Aug; 25(8):991-5. PubMed ID: 11571981
[TBL] [Abstract][Full Text] [Related]
12. Identification of genes associated with multiple nodules in hepatocellular carcinoma using cDNA microarray: multicentric occurrence or intrahepatic metastasis?
Nakata T; Seki N; Miwa S; Kobayashi A; Soeda J; Nimura Y; Kawasaki S; Miyagawa S
Hepatogastroenterology; 2008; 55(84):865-72. PubMed ID: 18705285
[TBL] [Abstract][Full Text] [Related]
13. Differential proteomic analysis of hepatocellular carcinoma.
Corona G; De Lorenzo E; Elia C; Simula MP; Avellini C; Baccarani U; Lupo F; Tiribelli C; Colombatti A; Toffoli G
Int J Oncol; 2010 Jan; 36(1):93-9. PubMed ID: 19956837
[TBL] [Abstract][Full Text] [Related]
14. Expression of Raf kinase inhibitor protein in human hepatoma tissues by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionization time-of-flight methods.
Tsao DA; Shiau YF; Tseng CS; Chang HR
Indian J Cancer; 2016; 53(2):216-219. PubMed ID: 28071612
[TBL] [Abstract][Full Text] [Related]
15. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.
Luk JM; Lam CT; Siu AF; Lam BY; Ng IO; Hu MY; Che CM; Fan ST
Proteomics; 2006 Feb; 6(3):1049-57. PubMed ID: 16400691
[TBL] [Abstract][Full Text] [Related]
16. Distinction of intrahepatic metastasis from multicentric carcinogenesis in multifocal hepatocellular carcinoma using molecular alterations.
Chianchiano P; Pezhouh MK; Kim A; Luchini C; Cameron A; Weiss MJ; He J; Voltaggio L; Oshima K; Anders RA; Wood LD
Hum Pathol; 2018 Feb; 72():127-134. PubMed ID: 29180252
[TBL] [Abstract][Full Text] [Related]
17. Global proteomic profiling in multistep hepatocarcinogenesis and identification of PARP1 as a novel molecular marker in hepatocellular carcinoma.
Xu X; Liu Z; Wang J; Xie H; Li J; Cao J; Zhou L; Zheng S
Oncotarget; 2016 Mar; 7(12):13730-41. PubMed ID: 26883192
[TBL] [Abstract][Full Text] [Related]
18. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
[TBL] [Abstract][Full Text] [Related]
19. Comparative proteomics and molecular mechanical analysis in CDA-II induced therapy of LCI-D20 hepatocellular carcinoma model.
Fan HZ; Liu H; Zhang C; Gao DM; Xue Q; Chen J; Sun RX; Liu YK; Yang PY
J Cancer Res Clin Oncol; 2009 Apr; 135(4):591-602. PubMed ID: 18853186
[TBL] [Abstract][Full Text] [Related]
20. The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarcinoma: an immunohistochemical analysis of E-cadherin, alpha-catenin and beta-catenin.
Asayama Y; Taguchi Ki K; Aishima Si S; Nishi H; Masuda K; Tsuneyoshi M
Liver; 2002 Feb; 22(1):43-50. PubMed ID: 11906618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
